n.a. (STSI)

0.21
0.01 3.14
NASDAQ
Prev Close 0.20
Open 0.22
Day Low/High 0.19 / 0.22
52 Wk Low/High 0.13 / 1.08
Volume 627.31K
Exchange NASDAQ
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Interesting STSI Call Options For April 19th

Interesting STSI Call Options For April 19th

Investors in Star Scientific, Inc. saw new options become available this week, for the April 19th expiration.

Biotech Stocks on the Verge of Breakouts: Star Scientific

Biotech Stocks on the Verge of Breakouts: Star Scientific

This biotech stock trading for under $10 is within range of triggering a breakout trade.

First Week of August 2014 Options Trading For Star Scientific (STSI)

First Week of August 2014 Options Trading For Star Scientific (STSI)

Investors in Star Scientific, Inc. saw new options become available this week, for the August 2014 expiration.

5 Stocks Under $10 Making Big Moves

5 Stocks Under $10 Making Big Moves

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Commit To Purchase Star Scientific At $1, Earn 30%

Commit To Purchase Star Scientific At $1, Earn 30%

Investors considering a purchase of Star Scientific, Inc. stock, but cautious about paying the going market price of $1.40/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Investor Alert: Hagens Berman Notifies Star Scientific, Inc. Investors Of Class Action And May 24th Lead Plaintiff Deadline

Investor Alert: Hagens Berman Notifies Star Scientific, Inc. Investors Of Class Action And May 24th Lead Plaintiff Deadline

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is notifying investors in Star Scientific, Inc.

Star Scientific Subpoenaed by U.S. Attorney's Office

Star Scientific Subpoenaed by U.S. Attorney's Office

A government investigation adds to Star Scientific's mounting problems.

Refuting Star Scientific's Refutation

Refuting Star Scientific's Refutation

Star Scientific still has questions to answer about anatabine.

The 5 Dumbest Things on Wall Street: Jan. 25

The 5 Dumbest Things on Wall Street: Jan. 25

Here is this week's roundup of the dumbest actions on Wall Street.

The Five Dumbest Things on Wall Street This Week: Jan. 25

The Five Dumbest Things on Wall Street This Week: Jan. 25

Gregg Greenberg skewers the biggest companies that made the best bloopers.

SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By Star Scientific, Inc.

SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By Star Scientific, Inc.

Levi & Korsinsky is investigating potential claims on behalf of purchasers of Star Scientific, Inc.

Star Scientific's Made-Up, Misleading Relationship With Johns Hopkins

Star Scientific's Made-Up, Misleading Relationship With Johns Hopkins

Johns Hopkins confirms it has no involvement with study of Star's nutritional supplement anatabine.

The Next Big Thing in Biotech: Worst CEO Candidates

The Next Big Thing in Biotech: Worst CEO Candidates

Adam Feuerstein, senior columnist for TheStreet, is assembling candidates for the Worst Biotech CEO of 2012 award.

The Fleecing of Star Scientific

The Fleecing of Star Scientific

Friday's financing transferred million of dollars from Star Scientific into the pockets of select shareholders.

Star Scientific Admits Legal Defeat, Warns Short on Cash

Star Scientific Admits Legal Defeat, Warns Short on Cash

Star Scientific's third-quarter report was both humiliating and humbling.

Lockheed Martin, Myrexis: After-Hours Trading

Lockheed Martin, Myrexis: After-Hours Trading

These stocks are among the most active in Friday's extended session.

Star Scientific Takes a Magical Mulligan On Failed Study Results

Star Scientific Takes a Magical Mulligan On Failed Study Results

Star changes results from an Anatabloc study without any explanation.

Biotech Stock Mailbag: Catalyst Pharma, Amarin, Star Scientific

Biotech Stock Mailbag: Catalyst Pharma, Amarin, Star Scientific

Biotech columnist Adam Feuerstein answers readers' questions about health-care companies

Star Scientific's 'Flint' Study Flops

Star Scientific's 'Flint' Study Flops

Star's dietary supplement Anatabloc has minimal effect on CRP levels in study.

Star Scientific: No Mention of Big Cash Payment in RJR Earnings Report (Update)

Star Scientific: No Mention of Big Cash Payment in RJR Earnings Report (Update)

Star Scientific appears to have received little or nothing from RJR in the settled patent lawsuit.

Star Scientific Silent on Tobacco Patent Settlement

Star Scientific Silent on Tobacco Patent Settlement

Did Star Scientific win big money from R.J. Reynolds?

Cramer's 'Mad Money' Recap: Looking for an Edge

Cramer's 'Mad Money' Recap: Looking for an Edge

Forget Apple and Google. Banco Santander holds the key to this market, Cramer said.

Star Will Ask For Approval Of Lower-toxin Tobacco

Star Scientific says it will ask FDA to approve new tobacco-making method early next year

FedEx, Beazer Homes, Netflix Are Big Movers

FedEx, Beazer Homes, Netflix, Wells Fargo, E-Trade are among big market movers Wednesday

RJ Reynolds Wins Patent Fight With Star Scientific

RJ Reynolds wins tobacco curing patent fight with Star Scientific; Star shares plummet

Court refuses to get involved in tobacco fight

Supreme Court refuses to get involved in tobacco patent fight

Friday's Winners & Losers: Star Scientific

Shares were up 42.8% for no discernable reason.